Biochemical evaluation of low dose of urokinase in acute myocardial infarction. A double-blind study.
D000208:Acute Disease; D001777:Blood Coagulation / Q000187:drug effects*; D002986:Clinical Trials as Topic; D003018:Clot Retraction; D003864:Depression, Chemical; D004341:Drug Evaluation; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D008259:Macroglobulins / Q000378:metabolism; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000201:enzymology; D010919:Placebos; D010958:Plasminogen / Q000378:metabolism; D010973:Platelet Adhesiveness / Q000187:drug effects; D011517:Prothrombin Time; D012712:Serum Globulins / Q000378:metabolism; D013268:Stimulation, Chemical; D013997:Time Factors; D000515:alpha 1-Antitrypsin / Q000378:metabolism
D005343:Fibrinolytic Agents; D008259:Macroglobulins; D010919:Placebos; D012712:Serum Globulins; D000515:alpha 1-Antitrypsin; D005340:Fibrinogen; D010958:Plasminogen